Skip to content Skip to menu

Appointment of new CEO

Wednesday, 24 August 2016

Media Release

Medicines Australia, the peak body representing the Innovative Medicines Industry has today announced the appointment of Mr Milton Catelin as the new Chief Executive Officer of the organisation.

Mr Catelin will commence the role from the week of 3 October 2016, after returning to Australia from the United Kingdom and will be based in Canberra.

Mr Catelin has vast experience in policy development and leadership roles both in Australia and overseas. He has two decades of experience within the Australian public service which has led to international leadership roles within policy institutions and industry associations.

“I am honoured to be appointed as the CEO of Medicines Australia which represents such an important part of the Australian health sector,” said Mr Catelin.

“Medicines Australia plays such a crucial role in advocacy and policy development to ensure that the Australian community has fast, affordable access to the latest innovative medicines and vaccines.”

“It will be a privilege to lead this important work on behalf of the members who are at the forefront of medical science innovation both in Australia and around the world.”

“I am looking forward to engaging with policy makers and the community about the wonderful work our members do to not only improve health outcomes for patients but also build the Australian economy through significant investment and jobs creation, particularly within Australia’s Universities, research centres and biotechnology businesses,” said Mr Catelin.

Medicines Australia Chairman Mr Wes Cook, congratulated Mr Catelin on his appointment as CEO.

“Milton Catelin is a fantastic appointment for Medicines Australia and on behalf of the members I congratulate him for taking on this important role for the innovative medicines industry,” said Mr Cook.

“I am confident Milton’s leadership of Medicines Australia will add further strength to our industry and benefit the patients we serve.”

“I’d also like to thank our interim CEO Lee Hill who has been in the role since February this year. Lee has done a tremendous job working with the Board, the secretariat and our members to restructure and revitalise Medicines Australia. This has been incredibly important work that means our new CEO will take over the reins of a strong organisation that is even better placed to represent the interests of the community and our members in this wonderful sector.”

“To ensure a smooth transition, Mr Hill will stay on at Medicines Australia beyond October and will help to finalise the governance and organisational restructure work he has led with the Board,” said Mr Cook.

For a more detailed biography and a photo of Milton Catelin please click here.

Contact:

James Boyce
Phone: 0423 239 265
Email:
James.Boyce@medicinesaustralia.com.au

Top